indieCV (part of SOSV) is a biotech investor and accelerator that has begun to turn more and more towards climate technology in recent years. The current collection is the 13th installment, for Fall 2022, and we’ve taken a closer look at the five most memorable ones.
Indebio He tells us that this group works very hard on diversity, in terms of gender and geography. The group has drawn companies from four countries – Brazil, Israel, Turkey and the United States are all represented – and 62% of CEOs in this batch are women. There is perhaps less diversity in educational levels for the IndieBio founders, who hold 17 Ph.D.s, and all of the founders have advanced academic degrees.
Companies are doing exceptionally well in the health field, with nine focusing on the health of the planet and four addressing challenges in human health. They approach problems from a range of different angles, including materials, food, industrial biotechnology, treatments, and diagnostics.
In the post-pandemic world, the accelerator has seen some changes to its program as well. Before 2020, all companies were expected to travel to San Francisco for four months, but those days are gone. Today, the 13 cohort companies are part of a hybrid program.
“It’s more than just money,” managing director Po Bronson said in an email to TechCrunch, referring to the accelerator’s “smart money” cut, “although the fact that we doubled our investment offer to $525,000 doesn’t hurt.”
Let’s take a look at the five most interesting companies in this IndieBio collection — and what we love about them.